[DGP2-01]DG2023-60: Lifecycle Management of Anti-Drug Anitibody Assays
*Tsunenori Nakazawa1, Yukihiro Otsuka2, Tomoko Kojima3, Sae Niimura4, Suguru Hanari5, Kosuke Fukuda6, Motohiko Morihara7, Yukako Taniguchi4(1. Daiichi Sankyo Co., Ltd., 2. Sekisui Medical Co., Ltd., 3. Sunplanet Co., Ltd., 4. Shin Nippon Biomedical Laboratories, Ltd., 5. CMIC, Inc., 6. Sumitomo Pharma Co., Ltd., 7. Ono Pharmaceutical Co., Ltd.)
Keywords:
Anti-Drug Antibody,Critical reagent,Life Cycle Management
Password required to view
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
Password is required to view the abstract. Please enter a password to authenticate.
